CHF 5074
97%
- Product Code: 100049
CAS:
749269-83-8
| Molecular Weight: | 325.16 g./mol | Molecular Formula: | C₁₆H₁₁Cl₂FO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
CHF 5074 is being studied for its potential therapeutic applications in neurodegenerative diseases, particularly Alzheimer's disease. It has shown promise in reducing amyloid-beta plaque formation, which is a hallmark of Alzheimer's pathology. Additionally, it exhibits anti-inflammatory properties, which may help in mitigating neuroinflammation associated with cognitive decline. Research is ongoing to explore its efficacy and safety as a treatment option for Alzheimer's and other related conditions.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | £125.59 |
+
-
|
| 25.000 | 10-20 days | £412.60 |
+
-
|
CHF 5074
CHF 5074 is being studied for its potential therapeutic applications in neurodegenerative diseases, particularly Alzheimer's disease. It has shown promise in reducing amyloid-beta plaque formation, which is a hallmark of Alzheimer's pathology. Additionally, it exhibits anti-inflammatory properties, which may help in mitigating neuroinflammation associated with cognitive decline. Research is ongoing to explore its efficacy and safety as a treatment option for Alzheimer's and other related conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :